On 2024-05-09, eFFECTOR Therapeutics, Inc. (EFTR) announced earnings per share of $-2.16 for the fiscal quarter ending 2024-03-31, beating the average analyst estimate of $-2.17.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-09 | 2024-03-31 | $-2.17 | $-2.16 |
| 2024-03-25 | 2023-12-31 | $-2.73 | $-3.42 |
| 2023-11-13 | 2023-09-30 | $-3.25 | $-3.25 |
| 2023-08-08 | 2023-06-30 | $-4.75 | $-4.25 |
| 2023-05-09 | 2023-03-31 | $-5.50 | $-6.00 |
| 2023-03-08 | 2022-12-31 | $-4.50 | $-5.50 |
| 2022-11-07 | 2022-09-30 | $-6.75 | $-5.75 |
| 2022-08-09 | 2022-06-30 | $-4.50 | $-4.25 |
| 2022-05-10 | 2022-03-31 | $-8.00 | $1.75 |
| 2022-03-16 | 2021-12-31 | $-6.25 | $11.00 |
| 2021-11-08 | 2021-09-30 | $-5.75 | $10.50 |